Skip to Main Content
<< Back | Return to Main COMAR Search Page

7 records match your request.

FileAbstract
10.28.11.00.htm 10.28.11.00. Title 10 MARYLAND DEPARTMENT OF HEALTH Subtitle 28 BOARD OF EXAMINERS IN OPTOMETRY Chapter 11 Use of Diagnostic Pharmaceutical Agents Authority: Health Occupations Article, §11-101 and 11-404, Annotated Code of Maryland
10.28.11.01.htm 10.28.11.01. 01 Definitions.. A. In this chapter, the following terms have the meanings indicated.. B. Terms Defined.. 1) "Credit hour" means attendance in class for 1 hour. One credit hour is interpreted to mean 1 classroom hour.2) "Optometric management of ocular disease" means the use of optometric services and techniques to determine the most appropriate and timely referral for ocular disease.
10.28.11.02.htm 10.28.11.02. 02 Diagnostic Pharmaceutical Agents.. A. An optometrist certified by the Board as qualified to administer diagnostic pharmaceutical agents may use the following agents:1) Agents directly or indirectly affecting the pupil of the eye including the mydriatics and cycloplegics listed below:a) Phenylephrine hydrochloride (2.5 percent). b) Hydroxyamphetamine hydrobromide (1.0 percent). c) Cyclopentolate hydrochloride (0.5―2.0 percent). d) Tropicamide (0.5 and 1.0 percent).
10.28.11.03.htm 10.28.11.03. 03 Certification.. A. The Board will certify an optometrist licensed to practice in Maryland as qualified to administer diagnostic pharmaceutical agents if the licensed optometrist meets one of the following criteria:1) Graduation from an accredited school of optometry within 7 years before applying for certification in Maryland.2) Certification to use diagnostic pharmaceutical agents in another state which included completion of not less than 70 credit hours in diagnostic pha
10.28.11.04.htm 10.28.11.04. 04 Renewal of Certification.. A. An optometrist certified under this chapter shall complete 6 credit hours of continuing education every 2 years in the use of diagnostic pharmaceutical agents in the diagnosis and optometric management of ocular disease.B. The 6 credit hours of continuing education relating to the use of diagnostic pharmaceutical agents required every 2 years to maintain certification may be included as part of the hours of continuing education required for
10.28.11.05.htm 10.28.11.05. 05 Reporting.. An optometrist certified to use diagnostic pharmaceutical agents shall report to the Board, on the form provided by the Board, any incident of adverse reaction to the administration of diagnostic pharmaceutical agents.
10.28.11.9999.htm 10.28.11.9999. Administrative History Effective date: May 14, 1990 (17:9 Md. R. 1090). Regulation .02A, B amended effective November 20, 1994 (21:33 Md. R. 1933). Regulation .03 amended effective March 4, 2002 (29:4 Md. R. 417). Regulation .04 amended effective November 20, 1994 (21:33 Md. R. 1933).
<< Back | Return to Main COMAR Search Page